FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W201713537> ?p ?o ?g. }

• W201713537 abstract "This thesis aimed to address a gap in the strategic management literature whereby theories about the significance of alliances have been forwarded and accepted without adequate empirical evidence being provided to support their central thesis. The alliance activity of the dominant firms in the global pharmaceutical industry was studied and no consistent link was found between the involvement of these firms in research and development alliances and their performance over a range of indicators. This finding is not compatible with much of the current strategic management literature, which asserts that alliances are an essential part of the strategy of successful firms and that without these collaborative agreements, firm failure is inevitable. Further to this fmding, four of the firms were examined through detailed archival analysis over a longitudinal historical timeframe to determine the role of alliances in the overallstrategy of each firm. The strategic perspective taken in the research gives a holistic view of each firm through consideration of their alliance activity as well as a range of other important factors such as their acquisitions and divestments, executive changes, patents and marketing approvals, stock offerings, buy backs and legal proceedings. The results of this analysis show that successful firms may use one or more of a range of strategictools to ensure their continued profitability and ultimate survival. As an alternative to alliances, mergers or acquisitions may be used or as a third alternative, firms can choose to develop their internal resources. These fmdings support the concept, espoused by core management theorists, that strategy is unique. To address the lack of evidence in the literature, this research sought to gather evidence that would elucidate the nature of the connection between alliance activity and performance. For the dominant firms in the pharmaceutical industry the evidence hasshown that the role of alliances in the performance of these firms is uncertain and that there is no empirical basis for claims that alliances are essential to firm success.While further research may show that alliances are indeed imperative for small firms without the necessary capabilities, particularly those related to their human capital, to develop internally or the resources to grow through acquisition, there is no certainty thatthe dominant firms in this industry are forced into such imperatives. The smaller and newer biotechnology firms gain their competitive advantage through their innovativecapacity to produce potentially valuable new molecules. However, these firms do not possess within their human capital the complete range of skills, nor do they posses within their infrastructure the physical capabilities required to materialize from the promising molecule a marketable pharmaceutical product. In order for the promise of their innovations to be realized they must seek external inputs. This could come in the form of venture capital, but the investments required are so large and the risk for the investors so great that this path is rarely followed. Instead these firms enter into a dependency relationship with a larger, more resource rich firm. In this way the large numbers of firms potentially involved in the industry are dominated by a small number of firms who have the means to maintain for their own benefit the established dependencyrelationships. These dominant firms retain their strategic choice and may select from a range of options.Indeed it is the very dominance of these firms that creates the dependence of the smaller firms upon them. These conclusions should force a rethinking of the approach to theory development in this area, and for business decision makers, the findings should encourage revision of their strategy using a holistic, firm based perspective, through arecognition that the outcome of strategic decision making is always contingent upon the context in which the decisions must be made." @default.
• W201713537 created "2016-06-24" @default.
• W201713537 creator A5000109788 @default.
• W201713537 date "2002-01-01" @default.
• W201713537 modified "2023-09-23" @default.
• W201713537 title "The uncertain role of alliances in the strategic armoury of the dominant firms in the global pharmaceutical industry" @default.
• W201713537 hasPublicationYear "2002" @default.
• W201713537 type Work @default.
• W201713537 sameAs 201713537 @default.
• W201713537 citedByCount "1" @default.
• W201713537 countsByYear W2017135372014 @default.
• W201713537 crossrefType "dissertation" @default.
• W201713537 hasAuthorship W201713537A5000109788 @default.
• W201713537 hasConcept C10138342 @default.
• W201713537 hasConcept C111472728 @default.
• W201713537 hasConcept C120936955 @default.
• W201713537 hasConcept C129361004 @default.
• W201713537 hasConcept C138885662 @default.
• W201713537 hasConcept C144133560 @default.
• W201713537 hasConcept C162853370 @default.
• W201713537 hasConcept C17744445 @default.
• W201713537 hasConcept C181190989 @default.
• W201713537 hasConcept C199539241 @default.
• W201713537 hasConcept C2776474809 @default.
• W201713537 hasConcept C2778431023 @default.
• W201713537 hasConcept C2779652045 @default.
• W201713537 hasConcept C40700 @default.
• W201713537 hasConcept C548217281 @default.
• W201713537 hasConcept C71924100 @default.
• W201713537 hasConcept C86275758 @default.
• W201713537 hasConcept C98274493 @default.
• W201713537 hasConceptScore W201713537C10138342 @default.
• W201713537 hasConceptScore W201713537C111472728 @default.
• W201713537 hasConceptScore W201713537C120936955 @default.
• W201713537 hasConceptScore W201713537C129361004 @default.
• W201713537 hasConceptScore W201713537C138885662 @default.
• W201713537 hasConceptScore W201713537C144133560 @default.
• W201713537 hasConceptScore W201713537C162853370 @default.
• W201713537 hasConceptScore W201713537C17744445 @default.
• W201713537 hasConceptScore W201713537C181190989 @default.
• W201713537 hasConceptScore W201713537C199539241 @default.
• W201713537 hasConceptScore W201713537C2776474809 @default.
• W201713537 hasConceptScore W201713537C2778431023 @default.
• W201713537 hasConceptScore W201713537C2779652045 @default.
• W201713537 hasConceptScore W201713537C40700 @default.
• W201713537 hasConceptScore W201713537C548217281 @default.
• W201713537 hasConceptScore W201713537C71924100 @default.
• W201713537 hasConceptScore W201713537C86275758 @default.
• W201713537 hasConceptScore W201713537C98274493 @default.
• W201713537 hasLocation W2017135371 @default.
• W201713537 hasOpenAccess W201713537 @default.
• W201713537 hasPrimaryLocation W2017135371 @default.
• W201713537 hasRelatedWork W1517588365 @default.
• W201713537 hasRelatedWork W1560188803 @default.
• W201713537 hasRelatedWork W1981593226 @default.
• W201713537 hasRelatedWork W2013847564 @default.
• W201713537 hasRelatedWork W2074784020 @default.
• W201713537 hasRelatedWork W2168701355 @default.
• W201713537 hasRelatedWork W2207676991 @default.
• W201713537 hasRelatedWork W2216978472 @default.
• W201713537 hasRelatedWork W2253496590 @default.
• W201713537 hasRelatedWork W2758785045 @default.
• W201713537 hasRelatedWork W2795378562 @default.
• W201713537 hasRelatedWork W2944813638 @default.
• W201713537 hasRelatedWork W2954092810 @default.
• W201713537 hasRelatedWork W3093935393 @default.
• W201713537 hasRelatedWork W3121305065 @default.
• W201713537 hasRelatedWork W3122348675 @default.
• W201713537 hasRelatedWork W3122999452 @default.
• W201713537 hasRelatedWork W3124218595 @default.
• W201713537 hasRelatedWork W3125586366 @default.
• W201713537 hasRelatedWork W3125845870 @default.
• W201713537 isParatext "false" @default.
• W201713537 isRetracted "false" @default.
• W201713537 magId "201713537" @default.
• W201713537 workType "dissertation" @default.